Fatty liver infiltration in patients with COPD. An ECLIPSE cohort study
Mickael Martin (Quebec, Canada), Mickael Martin, Natalie Almeras, Jean-Pierre Després, Harvey O Coxson, George R. Washko, Isabelle Vivodtzev, Emiel F.M. Wouters, Erica Rutten, Michelle Williams, John Murchison, William MacNee, Don D. Sin, François Maltais
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mickael Martin (Quebec, Canada), Mickael Martin, Natalie Almeras, Jean-Pierre Després, Harvey O Coxson, George R. Washko, Isabelle Vivodtzev, Emiel F.M. Wouters, Erica Rutten, Michelle Williams, John Murchison, William MacNee, Don D. Sin, François Maltais. Fatty liver infiltration in patients with COPD. An ECLIPSE cohort study. Eur Respir J 2016; 48: Suppl. 60, 742
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Evaluation of asthma/COPD overlap within the ECLIPSE study Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016
The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013
Estimation of a disease progression model for COPD using data from the ECLIPSE study Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013
Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015
Comorbidities in Swedish COPD and non-COPD patients: ARCTIC study Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016
Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016
Comorbidities in patients with COPD and their impact on COPD course Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
Measurement properties of exacerbations of chronic pulmonary disease tool (EXACT) in a clinical trial of patients with moderate to severe COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Parametric response mapping of COPD phenotypes: A COPDGene study Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015
Comorbidities, gender-differences and COPD severity: The French Palomb cohort Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015
COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014
Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) Source: Eur Respir J 2008; 31: 869-873 Year: 2008
Renal impairment a neglected comorbidity in patients with COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016
Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016